封面
市場調查報告書
商品編碼
1703373

男性人工尿道括約肌市場-全球產業規模、佔有率、趨勢、機會與預測,按類型(帶球囊儲液器的澳洲尿道括約肌、帶彈簧的澳洲尿道括約肌)、按最終用戶、按地區和競爭情況細分,2020 年至 2030 年預測

Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (AUS with a balloon reservoir, AUS with a spring ), By End-user, By Region, & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球男性人工尿道括約肌市場價值為 2.5325 億美元,預計在預測期內將呈現強勁成長,到 2030 年年複合成長率(CAGR) 為 5.35%。尿失禁 (UI) 是一項重大的醫學挑戰,具有深遠的經濟和社會影響。男性尿失禁發生率的上升與泌尿系統疾病的增加密切相關,例如前列腺炎引起的尿失禁、手術干預導致的神經和肌肉損傷、感染以及其他損害正常膀胱功能的因素。

市場概覽
預測期 2026-2030
2024年市場規模 2.5325億美元
2030年市場規模 3.4703億美元
2025-2030 年複合年成長率 5.35%
成長最快的領域 附球囊儲液器的 AUS(3 組分)
最大的市場 歐洲

一個常見的潛在原因是良性前列腺增生(BPH)或前列腺增大,隨著年齡的成長而變得更加普遍。此外,攝護腺炎(攝護腺的發炎)也會引發尿失禁。手術,特別是涉及骨盆區域的手術,可能會導致神經或肌肉損傷,進一步導致男性失禁。

關鍵市場促進因素

人口老化日益加劇

主要市場挑戰

治療費用高昂

主要市場趨勢

採用微創手術

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球男性人工尿道括約肌市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型(帶球囊儲液器的 AUS(3 組分)、帶彈簧的 AUS(2 組分))
    • 按最終使用者(醫院、診所和其他醫療中心、學術和研究中心)
    • 按地區
    • 按公司分類(2024)
  • 產品市場圖

第6章:北美男性人工尿道括約肌市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲男性人工尿道括約肌市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章:亞太男性人工尿道括約肌市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章:南美男性人工尿道括約肌市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲男性人工尿道括約肌市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Affluent Medical
  • UroMems
  • Rigicon
  • ProMinent GmbH
  • Coloplast A/S
  • Medtronic Plc
  • Stryker

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16618

The global male artificial urinary sphincter market was valued at USD 253.25 million in 2024 and is expected to exhibit robust growth during the forecast period, registering a compound annual growth rate (CAGR) of 5.35% through 2030. Urinary incontinence (UI) represents a significant medical challenge with far-reaching economic and societal consequences. The rising incidence of male urinary incontinence is closely linked to an increase in urological disorders such as prostatitis-induced incontinence, nerve and muscle damage resulting from surgical interventions, infections, and other factors that impair normal bladder function.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 253.25 Million
Market Size 2030USD 347.03 Million
CAGR 2025-20305.35%
Fastest Growing SegmentAUS with a balloon reservoir (3-component)
Largest MarketEurope

A common underlying cause is benign prostatic hyperplasia (BPH), or prostate gland enlargement, which becomes more prevalent with advancing age. Additionally, prostatitis-an inflammation of the prostate-can also trigger incontinence. Surgical procedures, particularly those involving the pelvic region, may lead to nerve or muscle damage, further contributing to incontinence in men.

Key Market Drivers

Growing Aging Population

The global healthcare sector is undergoing a profound transformation, driven by a steady rise in the aging population. Increased life expectancy has led to a surge in age-related health conditions, with urinary incontinence emerging as a major concern. In 2017, the global population aged 60 and above reached approximately 962 million-more than double the 382 million recorded in 1980. According to long-term projections, this number is expected to exceed 2.1 billion by 2050.

This demographic shift is expanding the patient base for conditions such as urinary incontinence. Data shows that around 15% of older adults living independently and nearly 50% of those in long-term care facilities suffer from significant forms of UI. The aging process leads to physiological changes-including weakened pelvic muscles and hormonal imbalances-that heighten the risk of incontinence. Moreover, age-related conditions like BPH and prostatitis are among the leading contributors.

The growing demand for enhanced quality of life among the elderly population is a key growth driver for the male artificial urinary sphincter market. Urinary incontinence can have a substantial impact on an individual's day-to-day life, often resulting in social withdrawal, emotional distress, and diminished independence. As a result, healthcare professionals are increasingly recommending artificial urinary sphincters to restore continence and improve patient well-being.

Concurrently, technological advancements have significantly enhanced the functionality, comfort, and reliability of modern male artificial urinary sphincters. These innovations offer improved control, reduced risk of complications, and enhanced ease of use-making them a more attractive solution for older patients aiming to maintain independence and dignity.

Rising healthcare expenditure, both from governments and private providers, is further fueling the adoption of advanced medical technologies. The increasing focus on senior care has led to expanded investments in healthcare infrastructure, including devices like artificial urinary sphincters, which are integral to improving patient outcomes and supporting aging populatios.

Key Market Challenges

High Cost of Treatment

A major barrier to wider market adoption is the high cost associated with male artificial urinary sphincter implantation. The overall expense, encompassing both the surgical procedure and the device itself, can be considerable. This financial burden is particularly challenging for patients lacking adequate insurance coverage or access to affordable healthcare services, thereby limiting market penetration in some regions.

Key Market Trends

Adoption of Minimally Invasive Procedures

One of the emerging trends in the market is the increasing use of minimally invasive surgical techniques for the implantation of artificial urinary sphincters. These procedures, which involve smaller incisions and minimal tissue disruption, offer several advantages, including shorter recovery times, reduced post-operative discomfort, and lower risk of complications. As these approaches continue to evolve and become more accessible, they are expected to become the standard method for device implantation, further supporting market growth.

Key Market Players

  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Affluent Medical
  • UroMems
  • Rigicon
  • ProMinent GmbH
  • Coloplast A/S
  • Medtronic Plc
  • Stryker

Report Scope:

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Male Artificial Urinary Sphincter Market, By Type:

  • AUS with a balloon reservoir (3-component)
  • AUS with a spring (2-component)

Male Artificial Urinary Sphincter Market, By End-user:

  • Hospitals
  • Clinics & Other Healthcare Centers
  • Academic & Research Centers

Male Artificial Urinary Sphincter Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

Global Male Artificial Urinary Sphincter market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Male Artificial Urinary Sphincter Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
    • 5.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map

6. North America Male Artificial Urinary Sphincter Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Male Artificial Urinary Sphincter Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-user
    • 6.3.2. Canada Male Artificial Urinary Sphincter Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-user
    • 6.3.3. Mexico Male Artificial Urinary Sphincter Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-user

7. Europe Male Artificial Urinary Sphincter Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Male Artificial Urinary Sphincter Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-user
    • 7.3.2. United Kingdom Male Artificial Urinary Sphincter Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-user
    • 7.3.3. France Male Artificial Urinary Sphincter Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-user
    • 7.3.4. Italy Male Artificial Urinary Sphincter Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End-user
    • 7.3.5. Spain Male Artificial Urinary Sphincter Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End-user

8. Asia-Pacific Male Artificial Urinary Sphincter Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Male Artificial Urinary Sphincter Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-user
    • 8.3.2. Japan Male Artificial Urinary Sphincter Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-user
    • 8.3.3. India Male Artificial Urinary Sphincter Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-user
    • 8.3.4. Australia Male Artificial Urinary Sphincter Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End-user
    • 8.3.5. South Korea Male Artificial Urinary Sphincter Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End-user

9. South America Male Artificial Urinary Sphincter Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Male Artificial Urinary Sphincter Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-user
    • 9.3.2. Argentina Male Artificial Urinary Sphincter Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-user
    • 9.3.3. Colombia Male Artificial Urinary Sphincter Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-user

10. Middle East and Africa Male Artificial Urinary Sphincter Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End-user
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Male Artificial Urinary Sphincter Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End-user
    • 10.3.2. Saudi Arabia Male Artificial Urinary Sphincter Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End-user
    • 10.3.3. UAE Male Artificial Urinary Sphincter Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End-user
    • 10.3.4. Kuwait Male Artificial Urinary Sphincter Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Boston Scientific Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Zephyr Surgical Implants
  • 14.3. Affluent Medical
  • 14.4. UroMems
  • 14.5. Rigicon
  • 14.6. ProMinent GmbH
  • 14.7. Coloplast A/S
  • 14.8. Medtronic Plc
  • 14.9. Stryker

15. Strategic Recommendations

16. About Us & Disclaimer